Rituximab-induced acute severe thrombocytopenia.
Parajuli
Ritesh
R
Department of Medicine, Rosalind Franklin University of Medicine and Science, Mount Sinai Hospital, Chicago, IL, USA.
Hire
Ervin
E
Shah
Binay K
BK
D000208:Acute Disease; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy; D000069283:Rituximab; D013921:Thrombocytopenia / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab